Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Ludden

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|April 1, 1983
Sucralfate and warfarinD Mungall, R L Talbert, C Phillips, et al.
Investigational New Drugs|January 1, 1983
Characterization of the pharmacokinetics of bisantrene (NSC-337766)J G Kuhn, T M Ludden, J W Myers, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
Research Communications in Chemical Pathology and Pharmacology|April 1, 1980
Dose-dependence of the apparent half-life of phenytoin in the ratA Vicuna, D Lalka, P duSouich, et al.
Journal of Clinical Pharmacology|August 1, 1978
Procainamide accumulation kinetics in the immediate postmyocardial infarction periodD Lalka, M G Wyman, B N Goldreyer, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1979
Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humansA M Shepherd, T M Ludden, K D Haegele, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteersB Wang, T M Ludden, E N Cheung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigsT M Ludden, M S Bathala, L Malspeis, et al.
Journal of Clinical Pharmacology|January 1, 1981
Factors influencing procainamide total body clearance in the immediate postmyocardial infarction periodM G Wyman, B N Goldreyer, D S Cannon, et al.
Journal of Pharmaceutical Sciences|November 1, 1979
High-pressure liquid chromatographic assay for hydralazine in human plasmaT M Ludden, L K Goggin, J L McNay, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|April 1, 1983
Sucralfate and warfarinD Mungall, R L Talbert, C Phillips, et al.
Investigational New Drugs|January 1, 1983
Characterization of the pharmacokinetics of bisantrene (NSC-337766)J G Kuhn, T M Ludden, J W Myers, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
Research Communications in Chemical Pathology and Pharmacology|April 1, 1980
Dose-dependence of the apparent half-life of phenytoin in the ratA Vicuna, D Lalka, P duSouich, et al.
Journal of Clinical Pharmacology|August 1, 1978
Procainamide accumulation kinetics in the immediate postmyocardial infarction periodD Lalka, M G Wyman, B N Goldreyer, et al.
Research Communications in Chemical Pathology and Pharmacology|October 1, 1979
Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humansA M Shepherd, T M Ludden, K D Haegele, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteersB Wang, T M Ludden, E N Cheung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1978
Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigsT M Ludden, M S Bathala, L Malspeis, et al.
Journal of Clinical Pharmacology|January 1, 1981
Factors influencing procainamide total body clearance in the immediate postmyocardial infarction periodM G Wyman, B N Goldreyer, D S Cannon, et al.
Journal of Pharmaceutical Sciences|November 1, 1979
High-pressure liquid chromatographic assay for hydralazine in human plasmaT M Ludden, L K Goggin, J L McNay, et al.
Pageof 13